Objectives: To reduce short-term complications of radical cystectomy (RC) and intestinal urinary diversion with vescica ileale Padovana (VIP) neobladder, we described and assessed an enhanced recovery protocol (ERP) in a series of consecutive patients. Methods: An ERP was introduced focusing on reduced bowel preparation, standardized feeding and analgesic regimens. We analyzed the outcomes with all patients consecutively undergoing RC and VIP neobladder who met the following inclusion criteria: American Society of Anesthesiologists score <3; absence of malnutrition according to the Mini Nutritional Assessment - Short Form criteria; absence of inflammatory bowel diseases. Results: Thirty-one consecutive patients were recruited to undergo our ERP. Mean age of patients was 62.16 years. No patients died due to surgical complications. Nine of 31 patients experienced complications (29.03%), none requiring surgical intervention. According to Clavien grading, all complications were grade <2. Conclusion: The application of our ERP to our patients undergoing RC and VIP neobladder contributed to reduce postoperative morbidity.

Keywords:
Radical cystectomy, Urinary diversion, Orthotopic neobladder, Protocol, Complications
1.
Pagano F, Artibani W, Ligato P, et al: Vescica ileale Padovana: a technique for total bladder replacement. Eur Urol 1990;17:149-154.
2.
Fontana D, Destefanis P, Cugiani A: Evoluzione e progressi nel campo della sostituzione della vescica. Urologia 2007;74:49-52.
3.
Bassi E, Valerio S, Antoniazzi G, et al: Comparison between results of ileal conduit and continent ileal bladder (VIP), after radical cystectomy. Arch Esp Urol 1996;49:1003-1006.
4.
Novara G, De Marco V, Aragona M, et al: Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182:914-921.
5.
Stenzl A, Cowan NC, De Santis M, et al: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009;55:815-825.
6.
Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
7.
Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-1251.
8.
Dripps RD, Lamont A, Eckenhoff JE: The role of anesthesia in surgical mortality. JAMA 1961;178:261-266.
9.
Sobin DH, Witteking CH (eds): TNM Classification of Malignant Tumours, ed 6. New York, Wiley-Liss, 2002.
10.
Rubenstein LZ, Harker JO, Salva A, et al: Screening for undernutrition in geriatric practice: developing the Short-Form Mini Nutritional Assessment (MNA-SF). J Gerontol 2001;56A:M366-M377.
11.
Kaiser MJ, Bauer JM, Ramsch C, et al: Validation of the Mini Nutritional Assessment Short-Form (MNA®-SF): a practical tool for identification of nutritional status. J Nutr Health Aging 2009;13:782-788.
12.
Chang SS, Cookson MS, Baumgartner RG, et al: Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 2002;167:2012-2016.
13.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort 6,336 patients and results of a survey. Ann Surg 2004;240:205-213.
14.
Karl A, Seitz M, Staehler M, et al: Fast track approach in radical cystectomy. Urologe A 2011;50:1072-1075.
15.
Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJHM: Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev 2011;&#x200B;CD007635.
16.
Pantelis D, Wolff M, Overhaus M, Hirner A, Kalff JC: Fast-track surgery: perioperative management. Urologe A 2006;45:W1193-W1200.
17.
Arumainayagam N, McGrath J, Jefferson KP, Gillatt DA: Introduction of an enhanced recovery protocol for radical cystectomy. BJU Int 2008;101:698-701.
18.
Pruthi RS, Matthew Nielsen M, Smith A, et al: Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients. J Am Coll Surg 2010;210:93-99.
19.
Maffezzini M, Campodonico F, Capponi G, et al: Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch. Surg Oncol 2012;21:191-195.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.